
Protopic: A non-steroid ointment for eczema, used where steroids are hardest to keep using: the face, the eyelids, and skin folds. It carries a boxed warning that twenty years of follow-up have not supported. Vtama: A once-daily steroid-free cream for plaque psoriasis. It can be used anywhere on the body, including the face and skin folds, and some people stay clear for months after stopping.


Choose for eczema where steroids are hardest to keep using — face, eyelids, folds — or to prevent flares twice a week.
Choose for psoriasis or eczema anywhere on the body when you want a once-daily non-steroid with no time limit.
Can you take them together?
They can be used on different areas. Do not layer two steroid-free creams on the same spot.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.











Inhibits calcineurin: Blocks a switch that helps activate T cells. Reduces immune messengers: T cells release fewer inflammation-driving signals. Calms eczema and itch: Redness and irritation ease as inflammation settles.
The drug binds FKBP-12 and inhibits calcineurin, reducing T-cell cytokine transcription; the complete atopic-dermatitis mechanism is not known. It also has other cellular effects.

Activates AhR: Binds a receptor that helps regulate skin-cell behavior. May rebalance inflammation: Changes in immune signaling may help calm skin. May support the skin barrier: Changes in barrier proteins may help skin function.
Tapinarof is an AhR agonist; the specific therapeutic mechanisms are unknown. Anti-inflammatory and barrier effects are proposed from experimental evidence and are explicitly qualified.
When to Apply: A thin layer twice a day to the affected skin, rubbed in gently. It goes on the rash, not over clear skin. Keep moisturizer a couple of hours apart — layering one straight onto the other has not been studied.
How to Start: Twice a day until the patch clears, usually one to three weeks, then stop. Many people then move to maintenance — twice a week on the places that always flare, even when they look normal. That is well supported and makes flares less frequent.
If It Irritates: Burning or stinging for fifteen to thirty minutes after applying is very common in the first days and is not an allergy. It settles within about a week. Keeping the tube in the fridge, applying to dry rather than damp skin, and skipping alcohol early on all help.
If It's Not Working: Check it is going on twice a day — two to three weeks is a fair trial. Then the options are the higher strength if you are an adult on 0.03%, a short steroid course to break the flare, or a look at whether infection or a contact allergy is driving the rash.
When to Apply: Once a day, at whatever time you will remember. A thin layer over the plaques, rubbed in. It can go on the face, eyelids, armpits, groin and under the breasts, which sets it apart from a steroid. Wash your hands afterwards unless your hands are being treated.
How to Start: Once daily from day one, on every plaque you want treated. No ramp-up, and no cap on how much of the body can be covered, so it does not have to be rationed the way a strong steroid does.
If It Irritates: Small red bumps around hair follicles are the most common problem and usually appear in the first few weeks. Most are not infection and often settle without stopping. Stinging or a rash where you applied it is the other pattern, and that one is worth showing your doctor, because a true contact allergy means stopping.
If It’s Not Working: There is one strength, so there is nothing to increase. Give it a full twelve weeks. If plaques are still thick then, the conversation is about adding something else, phototherapy, or moving to a tablet or injection.
No blood tests are needed. Blood levels are usually undetectable with the ointment and fall further as the barrier repairs — the opposite of the oral form used after transplants. Monitoring is a check at two to three weeks on whether the rash responded, then a plan for maintenance.
The boxed warning is the part to understand. It says long-term safety is not established, that rare cases of lymphoma and skin cancer were reported in people who used these drugs, and that continuous long-term use should be avoided. It was added in 2006, based mainly on animal studies using very high doses by mouth or injection, plus scattered case reports.
What has happened since matters. Large cohort studies, and a registry that followed treated children for a decade, have not found the rise in lymphoma the warning describes. Guidelines in the United States and Europe still recommend these drugs, including on the face and eyelids and as twice-weekly maintenance. The concern was theoretical, more than twenty years of use has not borne it out, and how long to continue is still a decision to make with a doctor.
Day-to-day monitoring is simple: keep skin checks routine, use sun protection on treated areas, and pause during a skin infection.
No blood tests are required. There is nothing to check on a lab report, which is one of the practical arguments for a topical over a tablet.
Monitoring is a look at the skin and a conversation, usually at about twelve weeks. Two things get asked about: folliculitis, and whether it is a few bumps or enough to be a problem; and whether the treated skin has become itchy and inflamed in a new way, which points to contact dermatitis rather than psoriasis.
Long term there is no organ risk to track and no skin thinning to watch for, so there is no maximum duration. What is genuinely not known yet is what many years of continuous use looks like, because the drug is recent. A common pattern is to treat until clear, stop, and restart when plaques come back.
Approximate windows, not promises.
First few minutesApplying it: A thin layer twice a day. Burning or stinging for a short while afterward is common and worst in the first week.
First few minutesApplying it: A thin layer once a day on the plaques.
Days 1 to 7Adjusting: Burning is at its worst now. Itch often improves in the same week, which is what gets most people through.
Weeks 1 to 3Working: Redness and thickening settle and the burning has usually stopped. Most people reach their best result here.
MaintenanceKeeping flares apart: Once clear, twice-weekly use on the trouble spots lengthens the gaps between flares. Licensed, not an improvisation.
Weeks 1 to 4Starting: Scale and roughness ease before the redness does, often by week four. Folliculitis shows up now if it is going to, usually small tender bumps in hair-bearing areas.
Weeks 4 to 8Working: Plaques flatten and shrink, and color fades from red toward pink or brown.
Weeks 8 to 12Judge it here: Trials measured their main result at twelve weeks, and many people were still improving then. A meaningful minority reached clear or almost clear skin — a realistic target, not a promise.
After stoppingRemission: Unlike a steroid, it does not usually rebound. People who cleared completely often stayed clear for months before restarting.
Sorted by what to do about them.
Both strengths come as generics, which brought the price down a long way, though it still costs more than a generic steroid ointment. Prices vary widely between pharmacies and discount cards sometimes beat insurance, so check more than one.
Prior authorization is still common, usually asking that a topical steroid was tried first. Tube size is the practical variable: twice-daily use means a small tube treating a child's face lasts far longer than the same tube on two hands.
Brand only, with no generic. It is one of the more expensive topicals for psoriasis and costs far more than a generic steroid or generic calcipotriene.
Coverage varies and prior authorization is common; plans frequently want to see a topical steroid, and often a vitamin D analog, tried first. Manufacturer copay cards exist and the terms change, so check the current one.
Because a tube covers only so much, cost climbs quickly with widespread psoriasis, which is one of the main reasons people end up on a tablet or injection instead.
Yes, and it is printed on the label — long-term safety is not established, and rare cases were reported. Studies following large groups for years have not found the increased risk. A caution, not a demonstrated harm.
It acts on nerve endings in inflamed skin as well as on immune cells. Burning is worst in the first few days and gone within a week as the rash heals.
Yes — eyelid eczema is one of the main reasons it gets prescribed. Keep it off the eye itself and the lid margin.
Alcohol flushing is a known effect while using it. Harmless, and it stops when the treatment does.
The label asks for the shortest suitable use and for breaks. Twice-weekly maintenance on trouble spots is licensed and widely used. Make that decision with a doctor rather than leaving a prescription running.
No. Blood levels are usually undetectable with the ointment. The tablets are a different treatment entirely.
No. It works on a different switch inside the skin cell, the aryl hydrocarbon receptor. That is why there is no time limit and no skin thinning.
Yes — approved for the face and skin folds, one of its main advantages over a steroid.
Most likely folliculitis — small red bumps around hair follicles where you applied it. The most common side effect in the trials, at roughly one in five people, usually mild, and most carried on.
Give it twelve weeks. Some change usually shows by four.
That is a normal way to use it. In the long-term study, many who cleared completely stayed clear for months, then restarted when plaques returned.
Yes, it is also approved for atopic dermatitis, in adults and in children from age two.